These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7198476)

  • 21. Two open-label, randomized, crossover studies assessing the bioequivalence of ofloxacin administered as immediate-and extended-release formulations in healthy subjects.
    Marier JF; Ducharme MP; DiMarco M; Di Spirito M; Morelli G; Tippabhotla SK; Badri N; Rampal A; Monif T
    Clin Ther; 2006 Dec; 28(12):2070-80. PubMed ID: 17296463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamics and pharmacokinetics of pinacidil after a single dose of a new slow release tablet in healthy volunteers.
    Bareggi SR; Gambaro V; Valenti M; Benvenuti C
    Arzneimittelforschung; 1998 Jul; 48(7):730-3. PubMed ID: 9706373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability in man of atenolol and chlorthalidone from a combination formulation.
    McAinsh J; Holmes BH; Fitzsimons TJ; Young J
    Biopharm Drug Dispos; 1986; 7(3):223-31. PubMed ID: 3730522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and bioavailability of four modified-release ursodeoxycholic acid preparations for once-a-day administration.
    Simoni P; Sabatini L; Baraldini M; Mirasoli M; Roda A; Roda E
    Int J Clin Pharmacol Res; 2002; 22(2):37-45. PubMed ID: 12503774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
    Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
    Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonidine-chlorthalidone combination once and twice daily in essential hypertension.
    Noveck RJ; McMahon FG; Jain AK; Ryan JR
    Clin Pharmacol Ther; 1980 Nov; 28(5):581-6. PubMed ID: 7438676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common cold and influenza symptom management: the use of pharmacokinetic considerations to predict the efficacy of a twice-daily treatment for colds and flu.
    Stillings M; Little S; Sykes J
    Curr Med Res Opin; 2003; 19(8):791-9. PubMed ID: 14687451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacokinetics of clonidine following intravenous administration of high doses for the treatment of delirium tremens].
    Rominger KL; Schäfer E; Vrecko HG; Palme M
    Arzneimittelforschung; 1991 Apr; 41(4):399-401. PubMed ID: 1859513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL) , a new chronotherapeutic formulation.
    Sica D; Frishman WH; Manowitz N
    Heart Dis; 2003; 5(3):176-81. PubMed ID: 12783630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin-converting enzyme inhibition and the combination of a beta blocker and a diuretic are equally effective in lowering proteinuria in patients with glomerulonephritis.
    Kloke HJ; Wetzels JF; van Hamersvelt HW; Koene RA; Huysmans FT
    Nephrol Dial Transplant; 1993; 8(9):808-13. PubMed ID: 8255512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical study on the prolonged antihypertensive effect of clonidine in a sustained-release capsule formulation.
    Martens V; Bentsen P; Hochrein H
    Pharmatherapeutica; 1980; 2(7):456-61. PubMed ID: 7208540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability in man of atenolol and chlorthalidone from a combination formulation.
    McAinsh J; Bastain W; Young J; Harry JD
    Biopharm Drug Dispos; 1981; 2(2):147-56. PubMed ID: 7248478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers.
    Cainazzo MM; Pinetti D; Savino G; Bartiromo M; Forgione A; Bertolini A
    Drugs Exp Clin Res; 2005; 31(3):115-21. PubMed ID: 16033250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.
    Dulac O; Alvarez JC
    Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of a sustained-release dosage form of clomipramine.
    Herrera D; Mayet L; Galindo MC; Jung H
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1488-93. PubMed ID: 11185671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A newly developed precise and sensitive radioimmunoassay for clonidine.
    Arndts D; Stähle H; Struck CJ
    Arzneimittelforschung; 1979; 29(3):532-8. PubMed ID: 582739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioavailability study of two carbamazepine containing sustained release formulations after multiple oral dose administration.
    Wangemann M; Retzow A; Evers G; Mazur D; Schug B; Blume H
    Arzneimittelforschung; 1998 Dec; 48(12):1131-7. PubMed ID: 9893926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of extended-release and immediate-release formulations of galantamine at steady state in healthy volunteers.
    Zhao Q; Janssens L; Verhaeghe T; Brashear HR; Truyen L
    Curr Med Res Opin; 2005 Oct; 21(10):1547-54. PubMed ID: 16238894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.